Interferon gamma Blocker [EPC] - N0000193856

Pharmacologic Class Information

Pharmacologic Code N0000193856
Pharmacologic Name Interferon gamma Blocker
Pharmacologic Uses
  • interferon gamma (IFN╬│) blocking antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interferon gamma Blocker

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Interferon gamma Blocker [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
66658-501Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-505Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-510Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-522Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-523Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-524Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE
66658-525Gamifant Non-Proprietary Name: Emapalumab-lzsgInjectionIntravenousSwedish Orphan Biovitrum Ab (publ)ACTIVE